Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Dyax Corp. (DYAX)

-NasdaqGM
26.31 Down 0.33(1.24%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:26.64
Open:26.79
Bid:22.96 x 500
Ask:29.08 x 1000
1y Target Est:29.75
Beta:0.73
Earnings Date:Jul 27 - Jul 31 (Est.)
Day's Range:26.16 - 26.79
52wk Range:8.09 - 30.55
Volume:548,976
Avg Vol (3m):1,451,680
Market Cap:3.83B
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 1.24%3.83B
SHPGUp 1.04%48.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):44.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.19
Quarterly EPS Est (Jun-15) :-0.04
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-7.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback